Category: Becker’s ASC Review

Cardiology ASCs facing 'incongruent' payer denials 

Cardiology-specific ASCs are faced with new challenges as payers update policies amid these high-acuity procedures’ migration to the outpatient setting. 

What ASCs need to know before adding cardiology

Cardiology is one of the biggest opportunities for ASC growth as procedures are increasingly approved for the outpatient setting. 

Anesthesia machine market expected to hit $14B in 2024

The global market for anesthesia machines is expected to hit $14.1 billion in 2024, according to a July 29 report from FactMR. 

10 states with the worst healthcare systems in 2024

Mississippi was ranked last on a list of states with the best healthcare systems by personal finance website Wallethub. 

Ascension bulking ASC strategy amid hospital sell-off spree 

ASC growth is a component of St. Louis-based Ascension plans for growth amid a $3 billion operating loss in fiscal 2023. 

CHS sees record Q2 surgical volumes driven by ASCs

Franklin, Tenn.-based Community Health Systems has released its second-quarter operating results, showing a record number of surgical volume, driven in part by the system’s ASC presence. 

Optum's 2024 clinic closures: What ASCs need to know

Optum, the country’s largest employer of physicians and parent company of ASC chain SCA Health, has revealed plans to shutter several clinics so far in 2024. 

22,500-square-foot medical office building approved in Connecticut

The proposal for a 22,500-square-foot medical office building in Madison, Conn., has been approved by the city’s Planning & Zoning Commission, according to a July 29 report from the New Haven Register.

10 states with the best healthcare systems in 2024

Minnesota was ranked No. 1 on a list of states with the best healthcare systems by personal finance website Wallethub. 

FDA approves blood test for colon cancer screenings

The FDA has approved a new screening test for colorectal cancer that only requires a sample of blood, The New York Times reported July 29.